Table I.
PIGC mRNA expression | ||||
---|---|---|---|---|
Clinical parameter | Low | High | χ2 value | P-value |
Age, years | 0.302 | 0.583 | ||
≤55 | 60 | 65 | ||
>55 | 125 | 120 | ||
Sex | 6.496 | 0.011a | ||
Male | 136 | 113 | ||
Female | 49 | 72 | ||
AFP level | 22.544 | <0.001a | ||
Normal | 122 | 91 | ||
High | 15 | 49 | ||
Hepatitis | 5.716 | 0.017a | ||
No | 130 | 107 | ||
Yes | 47 | 67 | ||
Drinking | 3.612 | 0.057 | ||
No | 118 | 135 | ||
Yes | 67 | 50 | ||
T stage | 1.793 | 0.181 | ||
T1+T2 | 145 | 134 | ||
T3+T4 | 39 | 50 | ||
N stage | 5.354 | 0.021a | ||
N0 | 116 | 136 | ||
N1+NX | 69 | 48 | ||
M stage | 9.264 | 0.002a | ||
M0 | 63 | 37 | ||
M1+MX | 122 | 148 | ||
G stage | 14.978 | <0.001a | ||
G1+G2 | 134 | 98 | ||
G3+G4 | 51 | 87 | ||
TNM stage | 1.502 | 0.22 | ||
I+II | 133 | 123 | ||
III+IV | 40 | 50 |
P<0.05. HCC, hepatocellular carcinoma; PIGC, phosphatidylinositol glycan anchor biosynthesis class C; TNM, tumor node metastasis; AFP, α-feroprotein; G, grade.